Patent · US Active

Antibody Fc mutants with ablated effector functions

US10053513B2 · kind B2 · utility

12Cited by

8References

5Claims

0Family size

Assignee

JANSSEN BIOTECH, INC. · US

Inventors

Stephen McCarthy · West Chester, US
Bernard Scallon · Collegeville, US
Susan Tam · Boothwyn, US
William Strohl · Bound Brook, US
Omid Vafa · Monrovia, US

Key dates

Filing date	Aug 5, 2015
Grant date	Aug 21, 2018
Priority date	—
Expiry date	Aug 5, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibody and other Fc-containing molecules with variations in the Fc region with reduced binding to Fc gamma receptors and resulting activity and can be used in the treatment of various diseases and disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.